PUBLISHER: TechNavio | PRODUCT CODE: 1911101
PUBLISHER: TechNavio | PRODUCT CODE: 1911101
The global pharmaceutical contract manufacturing market is forecasted to grow by USD 73087.9 mn during 2024-2029, accelerating at a CAGR of 8.5% during the forecast period. The report on the global pharmaceutical contract manufacturing market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing complexity and cost of research and development, growing need to focus on core competencies, strong research funding.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
| Market Scope | |
|---|---|
| Base Year | 2025 |
| End Year | 2029 |
| Series Year | 2025-2029 |
| Growth Momentum | Accelerate |
| YOY 2025 | 7.7% |
| CAGR | 8.5% |
| Incremental Value | $73087.9 mn |
Technavio's global pharmaceutical contract manufacturing market is segmented as below:
By End-User
By Service
By Application
Geography
This study identifies the intensifying cost-containment pressures and pursuit of operational efficiency as one of the prime reasons driving the global pharmaceutical contract manufacturing market growth during the next few years. Also, rising demand for biological therapies and advent of big data will lead to sizable demand in the market.
The report on the global pharmaceutical contract manufacturing market covers the following areas:
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global pharmaceutical contract manufacturing market vendors that include AbbVie Inc., Almac Group Ltd., Baxter International Inc., Boehringer Ingelheim GmbH, Cadila Pharmaceuticals Ltd., Charles River Laboratories, Cmic Holdings Co. Ltd., Dalton Pharma Services, Dr Reddys Laboratories Ltd., Grifols SA, Laboratory Corp., Lonza Group Ltd., Lupin Ltd., Novotech Health Holdings, OPTIMAPHARM d.o.o., Parexel International Corp., PCI Pharma Services, Recipharm AB, Syneos Health, Thermo Fisher Scientific Inc.. Also, the global pharmaceutical contract manufacturing market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.